Allstate Insurance Company et al v. Belsky et al
Filing
49
PROTECTIVE ORDER re ECF No. 48 Stipulation. Signed by Magistrate Judge Carl W. Hoffman on 6/3/16. (Copies have been distributed pursuant to the NEF - JC)
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 1 of 17
1
2
3
4
5
6
7
DENNIS L. KENNEDY
Nevada Bar No. 1462
JOSEPH A. LIEBMAN
Nevada Bar No. 10125
JOSHUA P. GILMORE
Nevada Bar No. 11576
BAILEYKENNEDY
8984 Spanish Ridge Avenue
Las Vegas, Nevada 89148-1302
Telephone: 702.562.8820
Facsimile: 702.562.8821
DKennedy@BaileyKennedy.com
JLiebman@BaileyKennedy.com
JGilmore@BaileyKennedy.com
8
Attorneys for Defendants
9
10
UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
11
12
ALLSTATE INSURANCE COMPANY,
13 ALLSTATE PROPERTY & CASUALTY
INSURANCE COMPANY, ALLSTATE
14 INDEMNITY COMPANY, and ALLSTATE
FIRE & CASUALTY INSURANCE
15 COMPANY,
STIPULATED CONFIDENTIALITY
AGREEMENT AND PROTECTIVE
ORDER
Plaintiffs,
16
17
Case No. 2:15-cv-02265-MMD-CWH
vs.
18 MARJORIE BELSKY, MD, MARIO
TARQUINO, MD, MARJORIE BELSKY, MD,
19 INC. doing business as, INTEGRATED PAIN
SPECIALISTS, and MARIO TARQUINO, MD,
20 INC., DOES 1-100 and ROES 101-200,
21
Defendants.
22
23
24
25
26
27
28
Page 1 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 2 of 17
1
Plaintiffs ALLSTATE INSURANCE COMPANY, ALLSTATE PROPERTY &
2
CASUALTY INSURANCE COMPANY, ALLSTATE INDEMNITY COMPANY, and
3
ALLSTATE FIRE & CASUALTY INSURANCE COMPANY (collectively “Plaintiffs”), and
4
Defendants MARJORIE BELSKY, M.D., MARIO TARQUINO, M.D., MARJORIE BELSKY,
5
MD, INC. D/B/A INTEGRATED PAIN SPECIALISTS, and MARIO TARQUINO, MD, INC.
6
(collectively “Defendants”), by and through their respective attorneys of record, stipulate and agree
7
as follows:
8
9
Plaintiffs, and each of them, and Defendants, and each of them, are each referred to herein
as a “party” and collectively as the “parties.” Any reference to a party or a non-party means, unless
10
otherwise indicated, a natural person, firm, entity, corporation, partnership, proprietorship,
11
association, joint venture, wholly-owned direct or indirect subsidiary, division, affiliate, parent
12
company, and any other form of business organization or arrangement, and includes the party or
13
non-party’s officers, directors, managers, members, employees, agents, representatives,
14
shareholders, independent contractors, attorneys, accountants, and all other person(s) over whom
15
the party or non-party has control or which act or purport to act on their behalf. Any party or non-
16
party producing or disclosing Confidential Information (defined below) pursuant to this Stipulated
17
Confidentiality Agreement and Protective Order (“Protective Order”) is referred to herein as the
18
“producing party” or the “designating party,” and any party or non-party receiving or being given
19
access to Confidential Information is referred to herein as the “receiving party.”
20
I.
21
PURPOSES AND LIMITATIONS
Discovery in this action is likely to involve production of confidential, proprietary,
22
financial, commercial, private or highly personal and sensitive information for which special
23
protection from public disclosure is warranted. The parties wish to prevent the possibility of any
24
misuse or unnecessary disclosure of any information protected by a privacy right and/or
25
confidentiality. The purpose of this Protective Order is to provide a means for limiting access to,
26
and the use and disclosure of, protected documents and information that are produced in this
27
action, as well as expedite the flow of discovery and facilitate the prompt resolution of any disputes
28
over confidentiality.
Page 2 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 3 of 17
1
The parties are in possession of documents which may constitute private personal
2
information about non-parties that is protected by the Health Insurance Portability and
3
Accountability Act of 1996 (“HIPAA”), but which the parties may otherwise be required to
4
produce in this action. While “protected health information” is generally private information, 45
5
C.F.R. Section 164.512(e)(1) allows for certain use and disclosure of protected health information
6
in the course of any judicial proceeding either in response to (1) a discovery request where the
7
parties have agreed upon a qualified protective order and have presented it to the court or (2) a
8
court order.
9
II.
“CONFIDENTIAL INFORMATION”
10
“Confidential Information” shall mean and include information, testimony, interrogatory
11
responses, responses to requests for admissions, documents, materials, items and tangible things
12
produced, disclosed or otherwise exchanged in discovery in this action, regardless of the medium
13
or manner generated, stored or maintained (collectively, “Discovery Material”), (i) which has not
14
been made public, (ii) which constitutes protected health information (as defined under HIPAA)
15
pertaining to those non-parties identified (by initials) in Exhibit “A” to the Complaint for Damages
16
and Demand for Jury Trial [Dkt. #1-1], trade secrets, confidential research and development
17
information, know-how, proprietary data, commercial information, company policies or practices,
18
financial information, accounting information, business strategies, personnel files, and/or highly
19
personal and sensitive information, (iii) which the producing party maintains in confidence, and
20
(iv) which the producing party in good faith believes that the unprotected disclosure or production
21
of which may result in economic or competitive injury or harm to or invasion of its rights or the
22
rights of a non-party to this action.
23
III.
24
SCOPE
The protections conferred by this Protective Order cover not only Confidential Information
25
(as defined above), but also (1) any information copied or extracted from Discovery Material
26
containing Confidential Information; (2) all copies, excerpts, summaries, or compilations of
27
Discovery Material containing Confidential Information; and (3) any testimony, conversations, or
28
presentations by parties or their counsel that might reveal Confidential Information. However, the
Page 3 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 4 of 17
1
protections conferred by this Protective Order do not cover information that is in the public domain
2
or becomes part of the public domain through trial or otherwise and not due to any unauthorized
3
act or omission on the part of a receiving party. For purposes of this Protective Order, “tax
4
returns” shall not be declared as information or other material that is or has become part of the
5
public domain, unless such tax returns have been made publicly available pursuant to state or
6
federal law or otherwise have been voluntarily made publicly available by the taxpayer.
7
IV.
8
ACCESS TO, USE AND DISCLOSURE OF CONFIDENTIAL INFORMATION
4.1
Basic Principles. A receiving party may use Confidential Information that is
9
disclosed or produced by the producing party or by a non-party in connection with this action only
10
for prosecuting, defending, or attempting to settle this action and for no other purpose whatsoever.
11
Confidential Information may be disclosed only to the categories of persons and under the
12
conditions described in this Protective Order. Confidential Information must be stored and
13
maintained by a receiving party at a location and in a secure manner that ensures that access is
14
limited to the persons authorized under this Protective Order to receive or be given access to
15
Confidential Information. A receiving party shall exercise the same standard of due and proper
16
care with respect to the storage, custody, use, and/or dissemination of Confidential Information as
17
is exercised with respect to its own Confidential Information. A receiving party shall further take
18
all measures reasonably necessary to maintain the confidentiality of a producing party’s
19
Confidential Information and shall not permit or participate in the unauthorized production,
20
disclosure, or use of such Confidential Information.
21
22
23
Nothing herein shall preclude the producing party from using or disclosing its own
Confidential Information.
4.2
Use of Confidential Information in Depositions. Any party shall have the right to
24
use and disclose Confidential Information at depositions unless otherwise agreed in writing by the
25
parties or on the record at the deposition. If a third party deponent (or non-party who is not
26
authorized to receive Confidential Information under this Protective Order) is present at the
27
deposition, that third party deponent or non-party shall be required to execute a copy of “Exhibit
28
A” attached to this Protective Order prior to dissemination or disclosure of any Confidential
Page 4 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 5 of 17
1
Information. Counsel for the affected party may otherwise request that all individual(s) not
2
qualified to obtain, receive or be given access to Confidential Information under this Protective
3
Order leave the deposition session during any portion(s) where Confidential Information is used or
4
referred to. The failure of a third party deponent or non-party to comply with such requests shall
5
constitute substantial justification for counsel for the affected party to advise the witness that he or
6
she need not answer the question pending. The party seeking to use or disclose Confidential
7
Information at the deposition may then raise the issue with the Court to determine if Confidential
8
Information can be used or disclosed at the deposition even though the third party deponent (or
9
non-party who is not authorized to receive Confidential Information under Section 4.3) refuses to
10
11
execute “Exhibit A.”
4.3
Disclosure of “Confidential Information.” Unless otherwise ordered by the Court or
12
permitted in writing by the designating party, a receiving party may disclose Confidential
13
Information only to:
14
15
16
(a)
its counsel of record in this action, as well as employees of its counsel to
whom it is reasonably necessary to disclose such information for this action;
(b)
its officers, directors, and employees (including in house counsel) to whom
17
disclosure is reasonably necessary for this action, unless the parties agree that a particular
18
document or material produced is for “Attorney’s Eyes Only” and is so designated;
19
20
(c)
experts and consultants to whom disclosure is reasonably necessary to
perform work for this action;
21
(d)
the Court, court personnel, and court reporters and their staff;
22
(e)
copy or imaging services retained by counsel to assist in the duplication of
23
Discovery Material, provided that counsel for the receiving party retaining the copy or imaging
24
service instructs the service not to disclose any Confidential Information to persons not authorized
25
to receive Confidential Information under this Protective Order;
26
27
(f)
court reporter(s) and videographers(s) employed to record depositions or live
testimony in this action;
28
Page 5 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 6 of 17
1
(g)
during their depositions, witnesses in this action to whom disclosure is
2
reasonably necessary and who signs the Confidentiality Agreement attached as “Exhibit A” to this
3
Protective Order before being shown such Confidential Information, unless otherwise agreed by
4
the designating party or ordered by the Court;
5
6
(h)
custodian or other person who otherwise possessed or knew the information; and
7
8
9
the author or recipient of Discovery Material containing the information or a
(i)
any other person or non-party as to whom the parties in writing agree or that
the Court in this action designates.
Any person or non-party to whom Confidential Information is produced, disclosed or
10
revealed pursuant to subparts (c), (e), (f), (g), (h) or (i) of this Section shall first be given a copy of
11
this Protective Order and advised, in sum and substance, as follows: (i) that Confidential
12
Information is being disclosed pursuant to an Order of the Court and agreement of the parties; (ii)
13
that Confidential Information may not be disclosed or disseminated orally, or by any other means,
14
by such person or non-party to any other person or non-party not permitted to receive or have
15
access to such Confidential Information pursuant to this Protective Order; (iii) that Confidential
16
Information may not be used except for the purposes of this action as provided in this Protective
17
Order or by Order of the Court; (iv) that Confidential Information must remain in that person or
18
non-party’s custody until returned to counsel from whom the Confidential Information was
19
received; and (v) that any violation of this Protective Order may result in the imposition of
20
sanctions as the Court deems proper. Moreover, any person or non-party to whom Confidential
21
Information is or will be produced, disclosed or revealed pursuant to subparts (c), (g) or (i) of this
22
Section shall be required to execute a copy of form “Exhibit A” attached to this Protective Order
23
prior to dissemination of any Confidential Information. Proof of each written agreement provided
24
for under this Section shall be maintained by each of the parties while this action is pending and
25
disclosed to the other parties upon good cause shown and Order of the Court.
26
4.4
Disclosure of Protected Health Information. Within ten (10) calendar days of entry
27
of this Protective Order, the Plaintiffs shall supplement their initial disclosures to produce all non-
28
privileged documents in their possession, custody and control related to each of the non-parties
Page 6 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 7 of 17
1
identified (by initials) in Exhibit “A” to the Complaint for Damages and Demand for Jury Trial
2
[Dkt. #1-1], as revised pursuant to Plaintiffs’ First Supplement to its Fed. R. Civ. P. 26(a)
3
Disclosures, including, without limitation, protected health information concerning each of the
4
non-parties. Within fifteen (15) calendar days of receipt of such documents, and prior to any
5
further use or disclosure of a non-party’s protected health information, the Defendants will send
6
written notice (in English and Spanish), at their own expense, to each non-party at his or her last
7
known address, whether via certified mail, return receipt requested, overnight courier for expedited
8
delivery, or hand-delivery, of the intended use and disclosure of his or her protected health
9
information solely for purposes of this action, enclosing the form notice attached hereto as “Exhibit
10
B”. A copy of the notice to the non-party must also be delivered by email to the Plaintiffs. The
11
notice shall be given no less than fifteen (15) calendar days prior to any use or disclosure of the
12
non-party’s protected health information; shall include a copy of this Protective Order; and shall
13
indicate that the non-party has an opportunity to object in writing to the use or disclosure of his or
14
her protected health information in connection with this action. The non-party shall have fifteen
15
(15) calendar days to respond in writing to the notice. If no written objection from the non-party is
16
received by the Defendants in response to the notice upon expiration of the 15-day period, any
17
party may thereafter use and disclose the non-party’s protected health information in accordance
18
with this Protective Order. If written objection (or any other form of writing) is received from the
19
non-party by the Defendants within the 15-day period, a copy shall be delivered by email to the
20
Plaintiffs, and the parties shall thereafter meet and confer in good faith regarding the non-party’s
21
objection. All parties shall be copied on written communications with a non-party concerning this
22
provision. If the parties are unable to informally resolve the non-party’s objection, any party may
23
request a conference call with the Court or file a motion seeking to resolve it. If any party files a
24
motion, the motion shall be filed within fifteen (15) calendar days of the date in which the parties
25
are unable to informally resolve the individual non-party’s objection. A copy of the motion shall
26
be served on the non-party by first class U.S. mail. Until the motion is heard and decided by the
27
Court, no party will use or disclose the individual non-party’s protected health information.
28
Page 7 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 8 of 17
1
The parties acknowledge that this provision is not intended to prevent any party from using
2
or disclosing pertinent protected health information in this action, but rather, to address in good
3
faith and resolve any non-party’s objection to the use or disclosure of his or her protected health
4
information that is or may be extraneous or unrelated to this action.
5
V.
6
DESIGNATING CONFIDENTIAL INFORMATION
5.1
Exercise of Restraint and Care in Designating Material for Protection. Each party or
7
non-party that designates Discovery Material for protection under this Protective Order must take
8
care to limit any such designation to specific material that qualifies under the appropriate
9
standards. The designating party must designate for protection only those parts of Discovery
10
Material that qualify, so that other portions of the Discovery Material for which protection is not
11
warranted are not swept unjustifiably within the ambit of this Protective Order.
12
Mass, indiscriminate, or routinized designations are prohibited. If it comes to a designating
13
party’s attention that Discovery Material that it designated for protection does not qualify for
14
protection, it must promptly notify all other parties that it is withdrawing the mistaken designation.
15
5.2
Manner and Timing of Designations. Except as otherwise provided in this Protective
16
Order, or as otherwise agreed in writing by the parties or ordered by the Court, disclosure of
17
Discovery Material that qualifies for protection under this Protective Order must be clearly so
18
designated before or when it is produced. A designation shall subject the Discovery Material to
19
this Protective Order without any further act on the part of the producing party.
20
(a)
Confidential Information in documentary form: (e.g., paper or electronic
21
documents and deposition exhibits, but excluding transcripts of depositions or other pretrial or trial
22
proceedings), the designating party must, at its own expense, affix the word “CONFIDENTIAL” to
23
each page that contains Confidential Information. Any designation under this Section shall take
24
place prior to production or disclosure by the producing party; however, in the event that any
25
Discovery Material is made available for inspection by a party, there will be no waiver of
26
confidentiality by the inspection of such Discovery Material by the inspecting party before they are
27
copied and produced with a confidential designation by the producing party. If Discovery Material
28
Page 8 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 9 of 17
1
is stored electronically or a confidential legend cannot otherwise be stamped or affixed upon it, the
2
producing party may designate it as “CONFIDENTIAL” by cover letter.
3
(b)
Testimony given in deposition or in other pretrial proceedings: the parties
4
(through their respective counsel) may identify on the record, during a deposition, hearing, or other
5
pretrial proceeding, all protected testimony, without prejudice to their right to so designate other
6
testimony after reviewing the transcript. The failure to make any designation on the record shall not
7
constitute a waiver of any party’s right to later designate all or portions of the transcript as
8
“CONFIDENTIAL.” When a designation has been made on the record, the testimony or the
9
transcript shall be disclosed only to those parties or non-parties described in Section 4.3 and to the
10
testifying third-party deponent, and the Confidential Information contained therein shall be used
11
only as specified in this Protective Order. Pages of transcribed deposition testimony and/or
12
exhibits to depositions that reveal or contain Confidential Information must be separately bound by
13
the court reporter and may not be disclosed to anyone except as permitted under this Protective
14
Order.
15
Irrespective of any designation made on the record, counsel must designate portions of a
16
deposition transcript, by page and line number(s), including any confidential exhibit(s) attached
17
thereto, as “CONFIDENTIAL” within thirty (30) days of receiving the transcript and
18
corresponding exhibit(s). Designations may be made by letter to counsel of record for the parties.
19
Portions of deposition transcripts so designated shall be treated as Confidential Information by the
20
parties as set forth herein. If all or a portion of a videotaped deposition is intended to be designated
21
as “CONFIDENTIAL,” the videocassette, videotape, DVD, CD-ROM or other electronic medium
22
storing or maintaining the deposition testimony shall be stamped or affixed “CONFIDENTIAL.”
23
All copies of deposition transcripts that contain Confidential Information shall be prominently
24
marked “CONFIDENTIAL” on the cover thereof. During the thirty (30) day review period
25
provided herein, the entire deposition transcript shall be treated as confidential, even if no
26
confidential designation was made on the record during the deposition. If no confidential
27
designation is made on the record or within the thirty (30) day review period, the entire transcript
28
Page 9 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 10 of 17
1
shall be considered non-confidential unless later designated by a party (subject to any other party’s
2
right to challenge such untimely designation).
3
(c)
Other tangible items: the producing party must, at its own expense, affix in a
4
prominent place on the exterior of the container or containers in which the information or item is
5
stored the word “CONFIDENTIAL.” If only a portion or portions of the information or item
6
warrant protection, the producing party, to the extent practicable, shall identify the protected
7
portion(s).
8
5.3
Inadvertent Failures to Designate. If timely corrected, an inadvertent failure to
9
designate as “CONFIDENTIAL” any Discovery Material does not, standing alone, waive the
10
designating party’s right to secure protection under this Protective Order for such Discovery
11
Material. Upon timely correction of a designation, the receiving party must make reasonable
12
efforts to ensure that the Discovery Material is treated in accordance with the provisions of this
13
Protective Order and destroy or return all previously produced copies of the undesignated
14
Discovery Material. Disclosure of any Discovery Material to any person prior to its later
15
designation shall not violate the terms of this Protective Order; however, written notice shall
16
promptly be given of such confidentiality to the person in accordance with Section 4.3 and, if
17
applicable, the person shall be required to sign “Exhibit A” attached hereto.
18
5.4
Designation of Documents Received from a Party or Non-Party. If any party
19
determines that any Discovery Material produced in this action by any other party should have
20
been designated as “CONFIDENTIAL,” it shall advise all other parties of this fact in writing within
21
thirty (30) days of the production. Such notice shall be accompanied by substitute copies of the
22
Discovery Material at issue, properly designated as “CONFIDENTIAL.”
23
Promptly, and in no event later than ten (10) days of receipt of any Discovery Material from
24
a non-party, whether in response to a subpoena or court order, the party receiving such Discovery
25
Material shall provide all parties in this action with copies thereof. Any party who reasonably
26
believes in good faith that any Discovery Material produced by a non-party contains Confidential
27
Information may, within thirty (30) days of receipt, designate the Discovery Material (or portions
28
thereof) as “CONFIDENTIAL.” Until this thirty (30) day review period expires, the parties shall
Page 10 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 11 of 17
1
treat all such Discovery Material produced by a non-party as confidential. If no objections or
2
confidential designations are made within the thirty (30) day review period, the Discovery Material
3
shall be considered non-confidential unless subsequently designated by a party (subject to any
4
other party’s right to challenge such untimely designation).
5
Any party issuing a subpoena to a non-party shall enclose a copy of this Protective Order
6
with the subpoena and advise the non-party that it may designate as “CONFIDENTIAL” any
7
Discovery Material that it produces in response to the subpoena or otherwise request that such
8
designation be made by the party issuing the subpoena before producing the Discovery Material in
9
this action. Any non-party invoking this Protective Order shall comply with, and be subject to, all
10
applicable provisions of this Protective Order.
11
VI.
12
CHALLENGING CONFIDENTIALITY DESIGNATIONS
6.1
Timing of Challenges. Any party may challenge a designation of confidentiality at
13
any time if it in good faith disputes a designation made by any other party or non-party. Unless a
14
prompt challenge to a designating party’s confidentiality designation is necessary to avoid
15
foreseeable, substantial unfairness, unnecessary economic burdens, or a significant disruption or
16
delay of this action, a party does not waive its right to challenge a confidentiality designation by
17
electing not to mount a challenge promptly after the original designation is made.
18
6.2
Meet and Confer. The parties must make every attempt to resolve any dispute
19
regarding confidential designations without court involvement. Any motion regarding confidential
20
designations or for a protective order must include a certification from counsel, whether in a
21
declaration or affidavit accompanying the motion, that the movant has engaged in a good faith
22
meet and confer with other affected parties in an effort to resolve the dispute without court action.
23
The certification must list the date, manner, and participants to the conference. A good faith effort
24
to confer requires a face-to-face meeting or a telephone conference after a written letter by counsel
25
from the party challenging the confidential designation setting forth the reason(s) for the challenge.
26
6.3
Judicial Intervention. If the parties cannot resolve a challenge without court
27
intervention, either party may file and serve a motion to determine the confidentiality of the disputed
28
Discovery Material. The burden of persuasion in any such motion shall be on the designating party.
Page 11 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 12 of 17
1
All parties shall continue to maintain the Discovery Material in question as confidential until the
2
Court rules on the challenge.
3
VII.
4
CONFIDENTIAL INFORMATION SUBPOENAED OR ORDERED PRODUCED IN
OTHER LITIGATION
5
If a party is served with a subpoena or a court order issued in other litigation that compels
6
disclosure of any Discovery Material designated in this action as “CONFIDENTIAL,” that party
7
must:
8
9
(a)
promptly notify the designating party in writing and include a copy of the
subpoena or court order;
10
(b)
promptly notify in writing the party who caused the subpoena or order to
11
issue in the other litigation that some or all of the material covered by the subpoena or order is
12
subject to this Protective Order. Such notification shall include a copy of this Protective Order;
13
and
14
(c)
cooperate with respect to all reasonable procedures sought to be pursued by
15
the designating party whose Confidential Information may be affected.
16
VIII. UNAUTHORIZED DISCLOSURE OF CONFIDENTIAL INFORMATION
17
If a receiving party learns of any possession, knowledge, use or disclosure of any
18
Confidential Information in any manner not authorized under this Protective Order, it must
19
immediately: (a) notify in writing the designating party of all pertinent facts relating to such
20
unauthorized possession, knowledge, use or disclosure, and include the name and address of each
21
person to whom disclosure was made; (b) use its best efforts to retrieve all unauthorized copies of
22
the protected Discovery Material and prevent further recurrence of any unauthorized possession,
23
knowledge, use or disclosure of Confidential Information; and (c) inform the person or persons to
24
whom unauthorized disclosures were made of the terms of this Protective Order.
25
IX.
26
27
28
INADVERTENT PRODUCTION OF PRIVILEGED OR OTHERWISE
PROTECTED MATERIAL
Nothing in this Protective Order abridges applicable law concerning inadvertent disclosure
of any Discovery Material that the producing party believes contains attorney-client
Page 12 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 13 of 17
1
communications, attorney work product, or otherwise privileged or protected information.
2
Disclosure of information that a producing party later claims should not have been disclosed
3
because of a privilege or other protection shall not constitute a waiver of, or estoppel as to, any
4
claim of privilege or other protection as to which the producing party would be entitled in this
5
action. When a producing party gives written notice to a receiving party that certain inadvertently
6
produced material is subject to a claim of privilege or other protection, the obligations of the
7
receiving party are those set forth in Federal Rule of Civil Procedure 26(b)(5)(B), Federal Rule of
8
Evidence 502, and Nevada Rule of Professional Conduct 4.4(b). This Section is not intended to
9
modify whatever procedure may be established in an e-discovery order or agreement that provides
10
for production without prior privilege review.
11
X.
12
13
FILING OF CONFIDENTIAL INFORMATION WITH THE COURT
Any Confidential Information that is filed with the Court by any party, or referenced in any
14
pleading, motion, brief or memorandum filed with the Court by any party, shall be filed and
LR IA 10-5
maintained under seal (or in redacted form) in compliance with LR 10-5(b). The party filing such
15
Confidential Information with the Court shall concurrently file a motion for leave to file
16
Confidential Information under seal and comply with the Ninth Circuit’s directives in Kamakana v.
17
City & County of Honolulu, 447 F.3d 1172 (9th Cir. 2006).
18
XI.
19
20
RESERVATION OF RIGHTS
The parties reserve the following rights:
(a)
Nothing in this Protective Order, nor the production or disclosure of any
21
Discovery Material under the terms of this Protective Order, nor any proceedings pursuant to this
22
Protective Order, shall be deemed or construed (i) to have the effect of an admission or a waiver by
23
either party of the confidentiality or non-confidentiality of any such Discovery Material; (ii) to alter
24
the confidentiality or the non-confidentiality of any such Discovery Material; (iii) to alter any
25
existing or pending obligation of any party or the absence thereof; or (iv) to affect in any way the
26
authenticity or admissibility of any document, testimony or other evidence at trial.
27
28
Page 13 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 14 of 17
1
(b)
The entry of this Protective Order shall be without prejudice to the rights of
2
the parties, or any of them, or of any non-party, to seek additional or different protection for
3
documents or information from the Court.
4
(c)
Each party may object to the production, disclosure or use of any Discovery
5
Material that a party designates as “CONFIDENTIAL” on any other ground(s) that it deems
6
appropriate, including, but not limited to, attorney-client privilege, work product, or any other
7
privilege or protection provided under applicable law.
8
9
(d)
This Protective Order shall neither enlarge nor affect the proper scope of
discovery in this action or any other litigation, nor shall this Protective Order be construed to
10
suggest that protected documents or information subject to this Protective Order are discoverable,
11
relevant or admissible in this action or any other litigation.
12
(e)
Nothing contained herein shall prejudice the right of any party to object to
13
the admissibility of Confidential Information subject to this Protective Order for any reason
14
permissible under applicable state or federal law.
15
(f)
The parties may notify any non-party to this action of the use or disclosure
16
of its Confidential Information by any party to this action, and entry of this Protective Order shall
17
not bar a non-party from seeking to preclude or limit any use or disclosure of its Confidential
18
Information in this action.
19
XII.
NON-TERMINATION AND RETURN OF DOCUMENTS
20
Within sixty (60) days after the termination of this action, including all appeals, each
21
receiving party must return all Confidential Information to the producing party, including all
22
copies, extracts and summaries thereof. Alternatively, the parties may agree upon appropriate
23
methods of destruction.
24
Notwithstanding this provision, counsel are entitled to retain one archival copy of all
25
documents filed with the Court, trial, deposition, and hearing transcripts, correspondence,
26
deposition and trial exhibits, expert reports, attorney work product, and consultant and expert work
27
product, and all other Discovery Material even if any of it contains Confidential Information.
28
Page 14 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 15 of 17
1
The confidentiality obligations imposed by this Protective Order shall remain in effect until
2
a designating party agrees otherwise in writing or the Court orders otherwise. All counsel of
3
record in this action shall comply with the terms of this Protective Order, and shall ensure that their
4
clients, and the persons or non-parties receiving or being given access to Confidential Information
5
pursuant to this Protective Order, similarly comply herewith. The parties shall not utilize any
6
portion of Confidential Information for their own personal or business advantage or gain, aside
7
from purpose(s) related to this action. In the event of a change in counsel for a party, new counsel
8
shall agree in writing to be bound by and subject to the terms of this Protective Order.
9
This Protective Order shall survive the termination of this action, and the Court shall retain
10
jurisdiction to resolve any dispute concerning the use or disclosure of Confidential Information
11
disclosed hereunder.
12
IT IS SO STIPULATED, THROUGH COUNSEL OF RECORD.
13
DATED this 2nd day of June, 2016.
DATED this 2nd day of June, 2016.
14
BAILEYKENNEDY
15
FAIN ANDERSON VANDERHOEF
ROSENDAHL O’HALLORAN SPILLANE
PLLC
16
By:
18
/s/Eron Z. Cannon
ERON Z. CANNON
701 Fifth Avenue, Suite 4750
Seattle, WA 98104
Attorneys for Plaintiffs
19
BREMER WHYTE BROWN & O’MEARA
21
/s/Joshua P. Gilmore
DENNIS L. KENNEDY
JOSEPH A. LIEBMAN
JOSHUA P. GILMORE
8984 Spanish Ridge Avenue
Las Vegas, NV 89148
Attorneys for Defendants
DATED this 2nd day of June, 2016.
20
By:
By:
17
22
23
/s/Nelson Cohen
NELSON COHEN
7670 West Lake Mead Blvd.
Las Vegas, NV 89128
Attorneys for Plaintiffs
24
25
26
27
28
IT IS ORDERED that the
IT IS SO ORDERED.
parties' stipulated protective
order (ECF No. 48) is
GRANTED subject to the court's
modification to page 13.
_________________________________
MAGISTRATE JUDGE
UNITED STATES DISTRICT JUDGE
June 3, 2016
Dated: ____________________
Page 15 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 16 of 17
1
“EXHIBIT A”
2
CONFIDENTIALITY AGREEMENT
3
4
5
I, ______________________________, do hereby acknowledge and agree, pursuant to 28
U.S.C. Section 1746, as follows:
1.
I have read the Stipulated Confidentiality Agreement and Protective Order (“the
6
Protective Order”) entered in Allstate Insurance Company, et al. v. Marjorie Belsky, MD, et al.,
7
Case No. 2:15-cv-02265-MMD-CWH, pending in the United States District Court for the District
8
of Nevada, and fully understand the contents thereof.
9
2.
I hereby agree and consent to be bound by the terms of the Protective Order and to
10
comply with it in all respects, and to that end, I hereby knowingly and voluntarily submit and
11
subject myself to the personal jurisdiction of the United States District Court, District of Nevada,
12
so that said court shall have the power and authority to enforce the Protective Order and to impose
13
appropriate sanctions upon me for knowingly violating the Protective Order, including punishment
14
for contempt of court for a knowing violation of the Protective Order.
15
3.
I understand that by signing this instrument, I will be eligible to receive
16
“Confidential Information” under the terms and conditions of the Protective Order. I further
17
understand and agree that I must treat any “Confidential Information” in accordance with the terms
18
and conditions of the Protective Order, and that, if I should knowingly make a disclosure of any
19
such information in a manner unauthorized by the Protective Order, I will have violated a court
20
order, will be in contempt of court, and will be subject to punishment by the court for such
21
conduct.
22
23
24
25
I declare under penalty of perjury that the foregoing is true and correct.
DATED:
(Signature)
(Printed Name)
26
27
28
(Address)
Page 16 of 17
Case 2:15-cv-02265-MMD-CWH Document 48 Filed 06/02/16 Page 17 of 17
1
“EXHIBIT B”
2
Dear [insert name of non-party]:
3
This office represents the Defendants in regard to the matter entitled Allstate Insurance
4
Company, et al. v. Marjorie Belsky, MD, et al., Case No. 2:15-cv-02265-MMD-CWH, pending in
5
the United States District Court for the District of Nevada (the “Lawsuit”).
6
As you may know, the Plaintiffs and Defendants are each in possession of your private
7
medical records related to a motor vehicle accident that occurred on or about [insert date of loss].
8
Notice is hereby given that the Plaintiffs and Defendants are required to use and disclose those
9
private medical records in the Lawsuit. Your private medical records are protected by the Health
10
Insurance Portability and Accountability Act of 1996, and will be used solely for purposes of the
11
Lawsuit. You may object to use or disclosure of your private medical records by sending a written
12
response to this letter via first class U.S. mail within fifteen (15) calendar days of the date of this
13
letter to BaileyKennedy at the following address: 8984 Spanish Ridge Ave., Las Vegas, Nevada
14
89148. Please specify the reasons for your objection in your letter. If a written objection is
15
received from you, the Plaintiffs and Defendants will determine if your objection can be resolved
16
by redacting portions of your private medical records. If the Plaintiffs and Defendants are not able
17
to resolve a dispute regarding your objection, they will involve the Court to make the final
18
determination. If you do not object in writing within 15 calendar days, your private medical
19
records will be used and disclosed in the Lawsuit in strict accordance with the terms of a Stipulated
20
Confidentiality Agreement and Protective Order, a copy of which is enclosed with this letter. This
21
means, for example, that your private medical records will be treated as confidential by the parties
22
and, absent Order of the Court, will not be subject to public disclosure.
23
Your prompt attention to this matter is greatly appreciated. Thank you.
24
25
26
27
28
Page 17 of 17
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?